Advertisement

ICER assessing valoctocogene roxaparvovec for haemophilia

    • 2 Accesses

    This is a preview of subscription content, log in to check access.

    Access options

    Buy single article

    Instant unlimited access to the full article PDF.

    US$ 49.95

    Price includes VAT for USA

    Subscribe to journal

    Immediate online access to all issues from 2019. Subscription will auto renew annually.

    US$ 214

    This is the net price. Taxes to be calculated in checkout.

    Reference

    1. Institute for Clinical and Economic Review. ICER to Assess Gene Therapy for Hemophilia A. Internet Document : 3 Jan 2020. Available from: URL: https://icer-review.org/announcements/icer-to-assess-gene-therapy-for-hemophilia-a/

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    ICER assessing valoctocogene roxaparvovec for haemophilia. PharmacoEcon Outcomes News 844, 2 (2020). https://doi.org/10.1007/s40274-020-6465-6

    Download citation